logo-loader

AtaiBeckley to participate in multiple June investor conferences

Published: 10:08 27 May 2026 EDT

conference

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) said members of its management team will participate in several investor conferences in June 2026, including the Jefferies Global Healthcare Conference in New York, the Oppenheimer CNS and Neuro-Muscular Summit in Miami, the HCW Neuro Perspectives Hybrid Conference and UBS Virtual CNS Day.

The clinical-stage biotech company said executives will take part in fireside chats, presentations and one-on-one meetings, with live and archived webcasts available on its investor relations website.

AtaiBeckley reports encouraging Phase 2a data for EMP-01 in social anxiety

AtaiBeckley Inc. CEO Dr Srinivas Rao joined Steve Darling from Proactive to discuss topline results from the company’s exploratory, double-blind, placebo-controlled Phase 2a trial evaluating EMP-01 in adults with Social Anxiety Disorder (SAD).The first-in-patient study met its primary safety...

on 03/03/2026